Acute Myeloid Leukemia Clinical Trial
Feasibility Pilot Exploring Variability in Biomarkers and PROs in AML
Summary
This research study is being conducted to help understand how the symptoms during treatment for acute myeloid leukemia (AML) may be affected by metabolism and how best to study this association. Symptoms include experiences like fatigue, sleep disturbance, pain, and depression.
Full Description
This is a prospective, longitudinal, observational exploratory study. Ten participants will be enrolled and will complete baseline and week 4 blood sample collections. Symptom questionnaires will be completed at baseline, 1-, 2-, 3- and 4-weeks.
This research study is a Pilot Study, which means it is the first time that researchers are studying the associations between symptoms and metabolism in this way.
The National Institute of Nursing Research is supporting this research study by providing funding for the research study.
Eligibility Criteria
Inclusion Criteria:
The Cantor Center CRC will attend weekly protocol meetings in the DFCI adult leukemia center to identify eligible patients and will confirm eligibility by reviewing the electronic health record and, if needed, contacting the treating physician. Subjects enrolled in clinical trials or other studies requiring extra blood samples and/or completion of questionnaires will be discussed with their oncology care team and/or investigators of the other study teams to ensure avoidance of excess subject burden. Only subjects deemed appropriate for enrollment without adding excess burden will be approached about this study.
Inclusion Criteria:
Adult (18+ years old)
New diagnosis of acute myeloid leukemia (AML)
Admitted to the DFCI Inpatient Hospital in the BWH for intensive induction chemotherapy (e.g., 7+3 regimen)
Eastern Cooperative Oncology Group Scale of Performance Status (ECOG PS) ≤ 3 OR Karnofsky Performance Status (KPS) ≥ 50
Ability to comprehend and speak English
Ability to provide informed consent
Exclusion Criteria:
Cognitive or psychiatric conditions prohibiting study consent or participation
Multiple primary cancers
A treating clinician reports that the subject is inappropriate for the study or that the study presents excess subject burden
Check Your Eligibility
Let’s see if you might be eligible for this study.
What is your age and gender ?
There is 1 Location for this study
Boston Massachusetts, 02115, United States
How clear is this clinincal trial information?